chr7-44104808-A-G
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_001129.5(AEBP1):āc.143A>Gā(p.Glu48Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000123 in 1,607,486 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001129.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AEBP1 | NM_001129.5 | c.143A>G | p.Glu48Gly | missense_variant | 1/21 | ENST00000223357.8 | |
AEBP1 | XM_011515162.2 | c.143A>G | p.Glu48Gly | missense_variant | 1/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AEBP1 | ENST00000223357.8 | c.143A>G | p.Glu48Gly | missense_variant | 1/21 | 1 | NM_001129.5 | P1 | |
AEBP1 | ENST00000455443.5 | c.17A>G | p.Glu6Gly | missense_variant | 1/6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 151930Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000220 AC: 51AN: 231702Hom.: 0 AF XY: 0.000220 AC XY: 28AN XY: 127018
GnomAD4 exome AF: 0.000121 AC: 176AN: 1455556Hom.: 0 Cov.: 32 AF XY: 0.000137 AC XY: 99AN XY: 723698
GnomAD4 genome AF: 0.000145 AC: 22AN: 151930Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74194
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.143A>G (p.E48G) alteration is located in exon 1 (coding exon 1) of the AEBP1 gene. This alteration results from a A to G substitution at nucleotide position 143, causing the glutamic acid (E) at amino acid position 48 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 30, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at